Clincosm LogoSign in Get a demo

mesothelioma, malignant

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Mesothelioma, Malignant Trial in China (Nivolumab, Ipilimumab, Pemetrexed)

Recruiting
  • Mesothelioma, Malignant
  • Nivolumab
  • +4 more
  • Beijing, Beijing, China
  • +25 more
Jan 17, 2023

Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
  • (no location specified)
Oct 5, 2022

Mesothelioma, Malignant Trial in Leicester (Niraparib Oral Product, Active Symptom Control)

Recruiting
  • Mesothelioma, Malignant
  • Niraparib Oral Product
  • Active Symptom Control
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust, Royal Leicester Inf
Jul 20, 2022

Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

Recruiting
  • Mesothelioma
  • +14 more
  • TC-510
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 14, 2022

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Mesothelioma, Malignant Trial in Toronto (Cyclophosphamide, Tremelimumab, Durvalumab)

Recruiting
  • Mesothelioma, Malignant
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 13, 2022

Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

Recruiting
  • Mesothelioma, Malignant
    • Shinjuku-ku, Tokyo, Japan
      Local Institution
    Apr 5, 2022

    Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

    Recruiting
    • Mesothelioma, Malignant
    • Leicester, United Kingdom
      University Hospitals of Leicester NHS Trust
    Apr 6, 2022

    Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced Trial in Beijing

    Not yet recruiting
    • Mesothelioma, Malignant
    • +2 more
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Dec 27, 2021

    Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant

    Not yet recruiting
    • Mesothelioma, Malignant
    • +2 more
    • PLEURAL BIOCOLLECTION OF MALIGNANT PLEURAL MESOTHELIOMA
    • (no location specified)
    Mar 30, 2021

    Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer Trial in Meldola (Pembrolizumab, Autologous dendritic cells,

    Recruiting
    • Mesothelioma, Malignant
    • +3 more
    • Meldola, FC, Italy
      Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
    Feb 25, 2021

    Mesothelioma, Malignant Trial in Rozzano (Gemcitabine, Imatinib mesylate)

    Completed
    • Mesothelioma, Malignant
    • Rozzano, MI, Italy
      Istituto Clinico Humanitas
    Jan 20, 2021

    11C-Methionine PET/CT Imaging in Patients Affected by Malignant

    Completed
    • Mesothelioma, Malignant
    • No intervention
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    Sep 29, 2020

    Mesothelioma, Malignant Trial in Worldwide (Placebo, Amatuximab, Pemetrexed)

    Terminated
    Has Results
    • Mesothelioma, Malignant
    • Placebo
    • +3 more
    • La Jolla, California
    • +48 more
    Mar 4, 2020

    Mesothelioma, Malignant Trial in Australia, United Kingdom (Regular Early Specialist Symptom Control Treatment (RESSCT))

    Completed
    • Mesothelioma, Malignant
    • Regular Early Specialist Symptom Control Treatment (RESSCT)
    • Nedlands, Western Australia, Australia
    • +18 more
    Jun 12, 2019